ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668257 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668257; 2) Community: the network communities that were significantly associated with the response to NSC 668257; 3) Molecule: the relationships between components within communities and NSC 668257; 4) MDR: the compounds that were significantly associated with the NSC 668257.

NSC Compound Enrichment Correlation
NSC 26273 6-Benzylthioinosine 0.0273093708703114 0.44148998
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0273093708703114 0.66148686
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.0273093708703114 0.51631246
NSC 351907 MASTOPARAN 0.0273093708703114 0.012102209
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0273093708703114 0.72805473
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0273093708703114 0.80214295
NSC 609699 Topotecan hydrochloride 0.0273093708703114 -0.07488971
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0273093708703114 0.58220539
NSC 626539 Null 0.0273093708703114 0.57179445
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.0273093708703114 0.41382691
Total:84  Current:56    [First] [Prev] [Next] [Last]